Pharmaceutical Compliance Monitor

Drug pricing is a complex and complicated area for business executives to navigate. Thus, it is a significant source of concern and stress.

Pharmaceutical Sales:  Balancing Profit, Patient Care, and Integrity Pharmaceutical sales teams are now required to “know” and “follow” ECCP’s highly regulated requirements to ensure compliance and integrity. The DOJ’s Criminal Division released an update to the use of personal devices, communication platforms, and messaging platforms. All companies are required to have policies and procedures to ensure employees are not using unapproved platforms for business communication.

Key considerations on the complex series of processes utilized to bring a new drug to market The average cost to launch a new drug has increased significantly in the last decade due to the rise in commercialization costs, more pressure from the payors, increased regulatory and compliance costs and shorter exclusivity periods.

Navigating the Intersection of Ethics and Sustainability in the Pharmaceutical Industry Introduction: The pharmaceutical industry, characterized by its commitment to improving global health outcomes, is undergoing a profound transformation as it grapples with the intertwined challenges of ethics and sustainability.

Allison Spagnolo Chief Privacy Officer, Senior Managing Director at Guidepost Solutions | Website | + posts Allison Spagnolo is a senior managing director at Guidepost Solutions and works on numerous compliance-based engagements involving financial institutions, healthcare organizations, government contractors, cryptocurrency exchanges and fintech companies.

The life sciences industry, encompassing healthcare, biotechnology, and pharmaceuticals, is a bastion of innovation. Yet, as it strides forward, the industry must reckon with its past and present shortcomings in diversity, equity, and inclusion (DEI). Addressing DEI is not just about rectifying historical wrongs but is crucial for fostering a culture of innovation, trust, and equity.

Strong momentum continues for the implementation and enforcement of state data privacy legislation in 2024, with Kentucky, Maryland, Nebraska New Hampshire and New Jersey enacting comprehensive data privacy laws in 2024. When combined with similar laws passed by various states in the prior year, there is a total of 17 comprehensive state privacy statutes that are currently in effect or slated to take effect over the next several years.